Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study (Q33732740)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study |
scientific article |
Statements
1 reference
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study (English)
1 reference
Julie Lotharius
Thomas Rückle
Stephan Chalon
Suzanne Elliott
Silvana Sekuloski
Caroline L Ng
Louise Marquart
Noelle S Williams
Nathalie Gobeau
Lidiya Bebrevska
Maria Rosario
Kennan Marsh
1 reference